1. Home
  2. SWVL vs SCYX Comparison

SWVL vs SCYX Comparison

Compare SWVL & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SWVL
  • SCYX
  • Stock Information
  • Founded
  • SWVL 2017
  • SCYX 1999
  • Country
  • SWVL United Arab Emirates
  • SCYX United States
  • Employees
  • SWVL N/A
  • SCYX N/A
  • Industry
  • SWVL Business Services
  • SCYX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SWVL Consumer Discretionary
  • SCYX Health Care
  • Exchange
  • SWVL Nasdaq
  • SCYX Nasdaq
  • Market Cap
  • SWVL 54.8M
  • SCYX 50.3M
  • IPO Year
  • SWVL N/A
  • SCYX 2014
  • Fundamental
  • Price
  • SWVL $6.32
  • SCYX $0.99
  • Analyst Decision
  • SWVL
  • SCYX Buy
  • Analyst Count
  • SWVL 0
  • SCYX 1
  • Target Price
  • SWVL N/A
  • SCYX N/A
  • AVG Volume (30 Days)
  • SWVL 28.1K
  • SCYX 212.5K
  • Earning Date
  • SWVL 01-07-2025
  • SCYX 11-06-2024
  • Dividend Yield
  • SWVL N/A
  • SCYX N/A
  • EPS Growth
  • SWVL N/A
  • SCYX N/A
  • EPS
  • SWVL 0.27
  • SCYX N/A
  • Revenue
  • SWVL $22,852,263.00
  • SCYX $8,566,000.00
  • Revenue This Year
  • SWVL $1,728.00
  • SCYX N/A
  • Revenue Next Year
  • SWVL N/A
  • SCYX $405.82
  • P/E Ratio
  • SWVL $17.32
  • SCYX N/A
  • Revenue Growth
  • SWVL N/A
  • SCYX N/A
  • 52 Week Low
  • SWVL $0.95
  • SCYX $0.90
  • 52 Week High
  • SWVL $21.94
  • SCYX $3.07
  • Technical
  • Relative Strength Index (RSI)
  • SWVL 56.25
  • SCYX 30.44
  • Support Level
  • SWVL $6.13
  • SCYX $0.90
  • Resistance Level
  • SWVL $6.75
  • SCYX $1.25
  • Average True Range (ATR)
  • SWVL 0.45
  • SCYX 0.08
  • MACD
  • SWVL -0.10
  • SCYX -0.01
  • Stochastic Oscillator
  • SWVL 26.67
  • SCYX 23.54

About SWVL Swvl Holdings Corp

Swvl Holdings Corp is a technology-driven mobility company that aims to provide reliable, safe, cost-effective and environmentally responsible mass transit solutions. Its technology and services provide commuters, travelers and businesses with an alternative to traditional public transportation, taxi companies or other ridesharing companies. The company's core product is B2C Swvl Retail offering, which provides riders with a network of minibuses and other vehicles running on fixed or semi-fixed routes within cities. Commuters use its Swvl mobile application to book rides between pre-defined pick-up points located throughout the city.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against a broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: